• Home
  • Search Results
  • Aberrant expression of ZNF268 alters the growth and migration of ovarian cancer cells.

Aberrant expression of ZNF268 alters the growth and migration of ovarian cancer cells.

Oncology letters (2013-08-16)
Li Hu, Wei Wang, Jinyang Cai, Jun Luo, Yi Huang, Shilu Xiong, Wenxin Li, Mingxiong Guo
ABSTRACT

Ovarian cancer is one of the most lethal gynaecological cancers worldwide. However, the mechanisms underlying ovarian carcinogenesis are not well understood. The present study used immunostaining, western blotting and quantitative real-time PCR to demonstrate that ZNF268 is overexpressed in human ovarian carcinomas. ZNF268-knockdown increased the viability, colony formation and growth of

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-ZNF268 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.